| Financial Year |
March 31 2023 |
| Monetary Funds |
805,699,924.74 |
| Held-for-trading Financial Assets |
1,594,825,334.21 |
| Notes Receivable |
83,372,587.59 |
| Accounts Receivable |
4,003,684,640.88 |
| Advances to Suppliers |
28,012,525.42 |
| Other Receivables |
85,176,153.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,190,866.36 |
| Inventories |
341,472,821.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
18,916,867.66 |
| Other Current Assets |
16,311,642.59 |
| Total Current Assets |
7,011,928,578.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
143,765,157.16 |
| Long-term Equity Investment |
236,010,229.70 |
| Investment Properties |
238,707,091.88 |
| Fixed Assetes |
657,756,562.90 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
201,551,258.01 |
| R&D expenses |
26,562,817.47 |
| Goodwill |
704,431,591.47 |
| Long-Term Deferred and Prepaid Expenses |
37,109,970.04 |
| Deferred Income Tax Assets |
226,507,256.80 |
| Other Non-Current Assets |
150,000,000.00 |
| Sub-Total of Non-Current Assets |
2,771,445,475.65 |
| Total Assets |
9,783,374,053.85 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,700,000.00 |
| Accounts Payable |
1,000,092,114.52 |
| Accounts Received In Advance |
14,440,812.05 |
| Employee Compensation Payable |
279,157,673.46 |
| Taxes Payable |
389,260,794.83 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
359,052,435.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
16,437,213.04 |
| Sub-Total of Current Liabilities |
2,231,328,362.28 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
56,837,099.94 |
| Special Payable |
-- |
| Estimatied Liabilities |
5,957,818.52 |
| Deferred Income Tax Liabilities |
50,827,333.48 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
197,652,557.39 |
| Total Liabilities |
2,428,980,919.67 |
| Paid-In Capital(Or Share Stock) |
952,603,538.00 |
| Capital Surplus |
2,246,359,959.85 |
| Surplus Reserve |
84,779,121.36 |
| LESS:Treasury Stock |
416,685,132.71 |
| Undistributed Profits |
4,485,276,006.17 |
| Minority Stockholder's Interest |
14,301,386.26 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,340,091,747.92 |
| Owner's Equity（Stockholder's Equity） |
7,354,393,134.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,783,374,053.85 |
